Continuing Professional Development
2 RACGP CPD Activity points available
This event will provide GPs with guidance on the identification and management of myocarditis and pericarditis following mRNA vaccination.
Myocarditis (inflammation of cardiac muscle) and/or pericarditis (inflammation of pericardium) following mRNA COVID-19 vaccines is predominantly seen in younger males including adolescents up to 2 weeks following vaccination.
By the end of this session, you will be able to:
- Identification and assessment of myocarditis and pericarditis following mRNA COVID-19 Vaccination
- Understanding management and referral guidelines
Dr. Scott Parsons - GP Clinical Editor, HealthPathways Melbourne.
A/Prof. Nigel Crawford - Director SAFEVIC, Chair, ATAGI.
Dr. Bryn Jones - Deputy Director of Cardiology - Royal Children’s Hospital.
GPs in the Eastern Melbourne PHN and North Western Melbourne PHN can access the Myocarditis and Pericarditis After mRNA COVID-19 Vaccines pathway on HealthPathways Melbourne. E-mail the team on email@example.com to retrieve your automatic login.